English
Insider transactions
EDGARGALERA THERAPEUTICS, INC.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-22.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–21 of 21
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-03 Filed 2026-08-05 | CHANG NANCY T Director · 10% owner | DDisposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | Disposed (D) | 47,434 | — | — | 0 | Direct (D) | No | F2, F3, F4
| Open filing 0001193125-26-335224 Read from the filing’s XML Dispute this row |
| 2026-08-03 Filed 2026-08-05 | CHANG NANCY T Director · 10% owner | DDisposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | Disposed (D) | 480 | — | — | 0 | Direct (D) | No | F2, F3, F5
| Open filing 0001193125-26-335224 Read from the filing’s XML Dispute this row |
| 2026-08-03 Filed 2026-08-05 | Alleva Lawrence M Director | DDisposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | Disposed (D) | 11 | — | — | 0 | Direct (D) | No | F1, F2, F3
| Open filing 0001193125-26-335215 Read from the filing’s XML Dispute this row |
| 2026-08-03 Filed 2026-08-05 | Alleva Lawrence M Director | DDisposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | Disposed (D) | 40 | — | — | 0 | Indirect (I) By the Lawrence M. Alleva Revocable Trust. | No | F1, F2, F3
| Open filing 0001193125-26-335215 Read from the filing’s XML Dispute this row |
| 2026-08-03 Filed 2026-08-05 | Alleva Lawrence M Director | DDisposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | Disposed (D) | 240 | — | — | 0 | Direct (D) | No | F1, F2, F4
| Open filing 0001193125-26-335215 Read from the filing’s XML Dispute this row |
| 2026-08-03 Filed 2026-08-05 | Sussman Joel F. Officer: Chief Accounting Officer | DDisposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | Disposed (D) | 10,000 | — | — | 0 | Direct (D) | No | F1, F2, F3, F4
| Open filing 0001193125-26-335196 Read from the filing’s XML Dispute this row |
| 2026-08-03 Filed 2026-08-05 | FRIEDMAN MICHAEL R. Director | DDisposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | Disposed (D) | 41,631 | — | — | 0 | Indirect (I) See Footnote | No | F3, F4, F5, F2
| Open filing 0001193125-26-335178 Read from the filing’s XML Dispute this row |
| 2026-08-03 Filed 2026-08-05 | FRIEDMAN MICHAEL R. Director | DDisposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | Disposed (D) | 480 | — | — | 0 | Direct (D) | No | F3, F4, F6
| Open filing 0001193125-26-335178 Read from the filing’s XML Dispute this row |
| 2026-08-03 Filed 2026-08-05 | LOKAY KEVIN G Director | DDisposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | Disposed (D) | 240 | — | — | 0 | Direct (D) | No | F1, F2, F3, F4
| Open filing 0001193125-26-335228 Read from the filing’s XML Dispute this row |
| 2026-08-03 Filed 2026-08-05 | Sorensen Mel Director · Officer: President and CEO | DDisposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | Disposed (D) | 975 | — | — | 0 | Direct (D) | No | F1, F2, F3
| Open filing 0001193125-26-335499 Read from the filing’s XML Dispute this row |
| 2026-08-03 Filed 2026-08-05 | Sorensen Mel Director · Officer: President and CEO | DDisposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | Disposed (D) | 30,000 | — | — | 0 | Direct (D) | No | F1, F2, F4
| Open filing 0001193125-26-335499 Read from the filing’s XML Dispute this row |
| 2026-05-15 Filed 2026-08-05 | CHANG NANCY T Director · 10% owner | CConversion of derivative security | Acquired (A) | 661,309 | — | — | 9,486,852 | Direct (D) | No | F1
| Open filing 0001193125-26-335224 Read from the filing’s XML Dispute this row |
| 2026-05-15 Filed 2026-08-05 | CHANG NANCY T Director · 10% owner | CConversion of derivative security | Disposed (D) | 661.309 | 0 | — | 0 | Direct (D) | No | F1
| Open filing 0001193125-26-335224 Read from the filing’s XML Dispute this row |
| 2026-05-15 Filed 2026-08-05 | FRIEDMAN MICHAEL R. Director | CConversion of derivative security | Acquired (A) | 2,989,399 | — | — | 8,326,269 | Indirect (I) See Footnote | No | F1, F2
| Open filing 0001193125-26-335178 Read from the filing’s XML Dispute this row |
| 2026-05-15 Filed 2026-08-05 | FRIEDMAN MICHAEL R. Director | CConversion of derivative security | Disposed (D) | 2,989.399 | 0 | — | 0 | Indirect (I) See Footnote | No | F1, F2
| Open filing 0001193125-26-335178 Read from the filing’s XML Dispute this row |
| 2026-05-15 Filed 2026-05-29 | Emerald Bioventures, LLC 10% ownerOpler Timothy 10% owner | CConversion of derivative security | Acquired (A) | 20,813,818 | — | — | 61,029,978 | Direct (D) | No | F1, F3, F2
| Open filing 0001123292-26-000772 Read from the filing’s XML Dispute this row |
| 2026-05-15 Filed 2026-05-29 | Emerald Bioventures, LLC 10% ownerOpler Timothy 10% owner | CConversion of derivative security | Disposed (D) | 20,813.8186 | — | — | 0 | Direct (D) | No | F3, F1, F2
| Open filing 0001123292-26-000772 Read from the filing’s XML Dispute this row |
| 2026-04-07 Filed 2026-04-09 | FRIEDMAN MICHAEL R. Director | CConversion of derivative security | Acquired (A) | 5,336,870 | — | — | 5,336,870 | Indirect (I) See Footnote | No | F1, F2
| Open filing 0000905148-26-001623 Read from the filing’s XML Dispute this row |
| 2026-04-07 Filed 2026-04-09 | FRIEDMAN MICHAEL R. Director | CConversion of derivative security | Disposed (D) | 5,336.87 | 0 | — | 2,989.399 | Indirect (I) See Footnote | No | F1, F2
| Open filing 0000905148-26-001623 Read from the filing’s XML Dispute this row |
| 2026-04-07 Filed 2026-04-09 | CHANG NANCY T Director · 10% owner | CConversion of derivative security | Acquired (A) | 1,180,611 | — | — | 8,825,543 | Direct (D) | No | F1
| Open filing 0000905148-26-001622 Read from the filing’s XML Dispute this row |
| 2026-04-07 Filed 2026-04-09 | CHANG NANCY T Director · 10% owner | CConversion of derivative security | Disposed (D) | 1,180.611 | 0 | — | 661.309 | Direct (D) | No | F1
| Open filing 0000905148-26-001622 Read from the filing’s XML Dispute this row |
Latest reported holdings
What each reporting owner last said they hold, as of the date shown. A transaction not yet filed is not in it.
| Reporting owner | Security | Shares owned after | Direct or indirect | Source |
|---|---|---|---|---|
| Alleva Lawrence M Director | Stock Option (Right to Buy) Derivative security · underlying Common Stock | 0 | D | As of 2026-08-03 Open filing 4 |
| Alleva Lawrence M Director | Common Stock | 0 | D | As of 2026-08-03 Open filing 4 |
| Alleva Lawrence M Director | Common Stock | 0 | I By the Lawrence M. Alleva Revocable Trust. | As of 2026-08-03 Open filing 4 |
| CHANG NANCY T Director · 10% owner | Series B Preferred Stock Derivative security · underlying Common Stock | 0 | D | As of 2026-05-15 Open filing 4 |
| CHANG NANCY T Director · 10% owner | Stock Option (Right to Buy) Derivative security · underlying Common Stock | 0 | D | As of 2026-08-03 Open filing 4 |
| CHANG NANCY T Director · 10% owner | Common Stock | 0 | D | As of 2026-08-03 Open filing 4 |
| Emerald Bioventures, LLC 10% owner | Series B Preferred Stock Derivative security · underlying Common Stock | 0 | D | As of 2026-05-15 Open filing 4 |
| Emerald Bioventures, LLC 10% owner | Common Stock | 40,216,160 | D | As of 2026-05-04 Open filing 3 |
| Emerald Bioventures, LLC 10% owner | Common Stock | 61,029,978 | D | As of 2026-05-15 Open filing 4 |
| FRIEDMAN MICHAEL R. Director | Series B Preferred Stock Derivative security · underlying Common Stock | 0 | I See Footnote | As of 2026-05-15 Open filing 4 |
| FRIEDMAN MICHAEL R. Director | Stock Option (Right to Buy) Derivative security · underlying Common Stock | 0 | D | As of 2026-08-03 Open filing 4 |
| FRIEDMAN MICHAEL R. Director | Common Stock | 0 | I See Footnote | As of 2026-08-03 Open filing 4 |
| LOKAY KEVIN G Director | Stock Option (Right to Buy) Derivative security · underlying Common Stock | 0 | D | As of 2026-08-03 Open filing 4 |
| Opler Timothy 10% owner | Series B Preferred Stock Derivative security · underlying Common Stock | 0 | D | As of 2026-05-15 Open filing 4 |
| Opler Timothy 10% owner | Common Stock | 40,216,160 | D | As of 2026-05-04 Open filing 3 |
| Opler Timothy 10% owner | Common Stock | 61,029,978 | D | As of 2026-05-15 Open filing 4 |
| Sorensen Mel Director · Officer: President and CEO | Stock Option (Right to Buy) Derivative security · underlying Common Stock | 0 | D | As of 2026-08-03 Open filing 4 |
| Sorensen Mel Director · Officer: President and CEO | Common Stock | 0 | D | As of 2026-08-03 Open filing 4 |
| Sussman Joel F. Officer: Chief Accounting Officer | Stock Option (Right to Buy) Derivative security · underlying Common Stock | 0 | D | As of 2026-08-03 Open filing 4 |
Joint filers each report the same shares, so rows are not added together.
Institutional holders (Form 13F)
No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.
Institutional ownership reported on Form 13F
No percent is shown: the cover-page share count is not available for this company.
- The lower figure counts positions a manager reports as its own with sole discretion. The upper figure counts every plain-share position and can count a share twice.
- Neither includes holders that do not file Form 13F, or managers below the filing threshold.
| Quarter | Managers holding | Shares, at least | Shares, at most | Filings read |
|---|---|---|---|---|
| 2026-09-30 | 0 | 0 | 0 | 8,935 |
| 2026-06-30 | 0 | 0 | 0 | 9,178 |
| 2026-03-31 | 1 | 93 | 93 | 9,173 |
| 2025-12-31 | 0 | 0 | 0 | 9,222 |
| 2025-09-30 | 0 | 0 | 0 | 8,469 |
| 2025-06-30 | 0 | 0 | 0 | 8,516 |
| 2025-03-31 | 0 | 0 | 0 | 8,518 |
| 2024-12-31 | 0 | 0 | 0 | 8,580 |
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read from their tags. Earlier schedules are free text: they are read only when every cover page states a share count and a percent, and the rest are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Ikarian Capital, LLC Common Stock, $0.001 par value per share | 0 | 0 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-352953 Dispute this row |
| Neil Shahrestani Common Stock, $0.001 par value per share | 0 | 0 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-352953 Dispute this row |
| Parvinder Singh Hyare Common stock, par value $0.001 per share (the "Common Stock") | 6.65 | 13,521,921.00 | 05/15/2026 Filed 2026-06-11 | SCHEDULE 13D | Open filing 0001104659-26-073025 Dispute this row |
| Emerald Bioventures, LLC Common stock, par value $0.001 per share (the "Common Stock") | 30.2 | 61,029,978 | 05/15/2026 Filed 2026-05-29 | SCHEDULE 13D/AAmendment 1 | Open filing 0001123292-26-000773 Dispute this row |
| Timothy Opler Common stock, par value $0.001 per share (the "Common Stock") | 30.2 | 61,029,978 | 05/15/2026 Filed 2026-05-29 | SCHEDULE 13D/AAmendment 1 | Open filing 0001123292-26-000773 Dispute this row |
| Emerald Bioventures, LLC Common stock, par value $0.001 per share (the "Common Stock") | 26.5 | 40,216,160 | 04/07/2026 Filed 2026-04-27 | SCHEDULE 13D | Open filing 0001123292-26-000583 Dispute this row |
| Timothy Opler Common stock, par value $0.001 per share (the "Common Stock") | 26.5 | 40,216,160 | 04/07/2026 Filed 2026-04-27 | SCHEDULE 13D | Open filing 0001123292-26-000583 Dispute this row |
| CHANG NANCY T Common stock, $0.001 par value per share | 5.9 | 8,921,543 | 12/30/2024 Filed 2026-04-10 | SCHEDULE 13D | Open filing 0000905148-26-001633 Dispute this row |
| Yair Schneid COMMON STOCK | 19.90 | 10,823,610 | — Filed 2024-05-16 | SC 13G/AAmendment 2Read from the cover page text | Open filing 0001213900-24-044071 Dispute this row |
| Alpha Pharma Investments LLC COMMON STOCK | 10.899 | 5,928,137 | — Filed 2024-05-16 | SC 13GRead from the cover page text | Open filing 0001213900-24-044069 Dispute this row |
| Rochel Soffer COMMON STOCK | 10.899 | 5,928,137 | — Filed 2024-05-16 | SC 13GRead from the cover page text | Open filing 0001213900-24-044069 Dispute this row |
| Yair Schneid COMMON STOCK | 19.90 | 10,823,610 | — Filed 2024-05-01 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0001213900-24-038572 Dispute this row |
| Yair Schneid COMMON STOCK | 13.073 | 7,110,801 | — Filed 2024-01-17 | SC 13GRead from the cover page text | Open filing 0001213900-24-003834 Dispute this row |
| GSA Capital Partners LLP (Name of Issuer) : Galera Therapeutics ORD | 7.156 | 3,892,561 | — Filed 2024-01-02 | SC 13GRead from the cover page text | Open filing 0001362033-24-000001 Dispute this row |
| Clarus IV-A, L.P. Common Stock, par value $0.001 per share | 1.0 | 542,555 | — Filed 2023-12-04 | SC 13D/AAmendment 1Read from the cover page text | Open filing 0001193125-23-288420 Dispute this row |
| Clarus IV-B, L.P. Common Stock, par value $0.001 per share | 0.7 | 353,661 | — Filed 2023-12-04 | SC 13D/AAmendment 1Read from the cover page text | Open filing 0001193125-23-288420 Dispute this row |
| Clarus IV-C, L.P. Common Stock, par value $0.001 per share | 1.2 | 652,324 | — Filed 2023-12-04 | SC 13D/AAmendment 1Read from the cover page text | Open filing 0001193125-23-288420 Dispute this row |
| Clarus IV-D, L.P. Common Stock, par value $0.001 per share | 0.2 | 130,444 | — Filed 2023-12-04 | SC 13D/AAmendment 1Read from the cover page text | Open filing 0001193125-23-288420 Dispute this row |
| Clarus IV Galera Royalty AIV, L.P. Common Stock, par value $0.001 per share | 1.0 | 550,661 | — Filed 2023-12-04 | SC 13D/AAmendment 1Read from the cover page text | Open filing 0001193125-23-288420 Dispute this row |
| Clarus IV GP, L.P. Common Stock, par value $0.001 per share | 4.1 | 2,229,645 | — Filed 2023-12-04 | SC 13D/AAmendment 1Read from the cover page text | Open filing 0001193125-23-288420 Dispute this row |
| Blackstone Clarus GP L.P. Common Stock, par value $0.001 per share | 4.1 | 2,229,645 | — Filed 2023-12-04 | SC 13D/AAmendment 1Read from the cover page text | Open filing 0001193125-23-288420 Dispute this row |
| Blackstone Clarus GP L.L.C. Common Stock, par value $0.001 per share | 4.1 | 2,229,645 | — Filed 2023-12-04 | SC 13D/AAmendment 1Read from the cover page text | Open filing 0001193125-23-288420 Dispute this row |
| Blackstone Holdings I L.P. Common Stock, par value $0.001 per share | 4.1 | 2,229,645 | — Filed 2023-12-04 | SC 13D/AAmendment 1Read from the cover page text | Open filing 0001193125-23-288420 Dispute this row |
| Blackstone Holdings I/II GP L.L.C. Common Stock, par value $0.001 per share | 4.1 | 2,229,645 | — Filed 2023-12-04 | SC 13D/AAmendment 1Read from the cover page text | Open filing 0001193125-23-288420 Dispute this row |
| Blackstone Inc. Common Stock, par value $0.001 per share | 4.2 | 2,289,605 | — Filed 2023-12-04 | SC 13D/AAmendment 1Read from the cover page text | Open filing 0001193125-23-288420 Dispute this row |
| Blackstone Group Management L.L.C. Common Stock, par value $0.001 per share | 4.2 | 2,289,605 | — Filed 2023-12-04 | SC 13D/AAmendment 1Read from the cover page text | Open filing 0001193125-23-288420 Dispute this row |
| Stephen A. Schwarzman Common Stock, par value $0.001 per share | 4.2 | 2,289,605 | — Filed 2023-12-04 | SC 13D/AAmendment 1Read from the cover page text | Open filing 0001193125-23-288420 Dispute this row |
| Altamont Pharmaceutical Holdings, LLC Common Stock | 12.02 | 5,280,000 | — Filed 2023-11-13 | SC 13GRead from the cover page text | Open filing 0001104659-23-117077 Dispute this row |
| Mark Pearson Common Stock | 12.02 | 5,280,000 | — Filed 2023-11-13 | SC 13GRead from the cover page text | Open filing 0001104659-23-117077 Dispute this row |
| Novo Holdings A/S Common Stock, $0.001 par value per share | 4.9 | 2,100,000 | — Filed 2023-06-28 | SC 13G/AAmendment 4Read from the cover page text | Open filing 0001193125-23-177520 Dispute this row |
| Deerfield Mgmt, L.P. Common Stock | 4.99 | 2,916,401 | — Filed 2023-02-28 | SC 13GRead from the cover page text | Open filing 0001193805-23-000248 Dispute this row |
| Deerfield Management Company, L.P. Common Stock | 4.99 | 2,916,401 | — Filed 2023-02-28 | SC 13GRead from the cover page text | Open filing 0001193805-23-000248 Dispute this row |
| Deerfield Partners, L.P. Common Stock | 4.99 | 2,916,401 | — Filed 2023-02-28 | SC 13GRead from the cover page text | Open filing 0001193805-23-000248 Dispute this row |
| James E. Flynn Common Stock | 4.99 | 2,916,401 | — Filed 2023-02-28 | SC 13GRead from the cover page text | Open filing 0001193805-23-000248 Dispute this row |
| Sectoral Asset Management Inc COMMON STOCK | 5.8 | 1,666,666 | — Filed 2023-02-13 | SC 13GRead from the cover page text | Open filing 0001104659-23-019589 Dispute this row |
| Jérôme G. Pfund COMMON STOCK | 5.8 | 1,666,666 | — Filed 2023-02-13 | SC 13GRead from the cover page text | Open filing 0001104659-23-019589 Dispute this row |
| Michael L. Sjöström COMMON STOCK | 5.8 | 1,666,666 | — Filed 2023-02-13 | SC 13GRead from the cover page text | Open filing 0001104659-23-019589 Dispute this row |
| Clarus IV-A, L.P. Common Stock, par value $0.001 per share | 1.9 | 542,555 | — Filed 2023-02-09 | SC 13DRead from the cover page text | Open filing 0001193125-23-030224 Dispute this row |
| Clarus IV-B, L.P. Common Stock, par value $0.001 per share | 1.2 | 353,661 | — Filed 2023-02-09 | SC 13DRead from the cover page text | Open filing 0001193125-23-030224 Dispute this row |
| Clarus IV-C, L.P. Common Stock, par value $0.001 per share | 2.3 | 652,324 | — Filed 2023-02-09 | SC 13DRead from the cover page text | Open filing 0001193125-23-030224 Dispute this row |
| Clarus IV-D, L.P. Common Stock, par value $0.001 per share | 0.5 | 130,444 | — Filed 2023-02-09 | SC 13DRead from the cover page text | Open filing 0001193125-23-030224 Dispute this row |
| Clarus IV Galera Royalty AIV, L.P. Common Stock, par value $0.001 per share | 1.9 | 550,661 | — Filed 2023-02-09 | SC 13DRead from the cover page text | Open filing 0001193125-23-030224 Dispute this row |
| Clarus IV GP, L.P. Common Stock, par value $0.001 per share | 7.7 | 2,229,645 | — Filed 2023-02-09 | SC 13DRead from the cover page text | Open filing 0001193125-23-030224 Dispute this row |
| Blackstone Clarus GP L.P. Common Stock, par value $0.001 per share | 7.7 | 2,229,645 | — Filed 2023-02-09 | SC 13DRead from the cover page text | Open filing 0001193125-23-030224 Dispute this row |
| Blackstone Clarus GP L.L.C. Common Stock, par value $0.001 per share | 7.7 | 2,229,645 | — Filed 2023-02-09 | SC 13DRead from the cover page text | Open filing 0001193125-23-030224 Dispute this row |
| Blackstone Holdings I L.P. Common Stock, par value $0.001 per share | 7.7 | 2,229,645 | — Filed 2023-02-09 | SC 13DRead from the cover page text | Open filing 0001193125-23-030224 Dispute this row |
| Blackstone Holdings I/II GP L.L.C. Common Stock, par value $0.001 per share | 7.7 | 2,229,645 | — Filed 2023-02-09 | SC 13DRead from the cover page text | Open filing 0001193125-23-030224 Dispute this row |
| Blackstone Inc. Common Stock, par value $0.001 per share | 7.8 | 2,274,605 | — Filed 2023-02-09 | SC 13DRead from the cover page text | Open filing 0001193125-23-030224 Dispute this row |
| Blackstone Group Management L.L.C. Common Stock, par value $0.001 per share | 7.8 | 2,274,605 | — Filed 2023-02-09 | SC 13DRead from the cover page text | Open filing 0001193125-23-030224 Dispute this row |
| Stephen A. Schwarzman Common Stock, par value $0.001 per share | 7.8 | 2,274,605 | — Filed 2023-02-09 | SC 13DRead from the cover page text | Open filing 0001193125-23-030224 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
3,104,499 filings read, dated 1980-01-02 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 258,595 |
| 2016 | 246,472 |
| 2017 | 244,814 |
| 2018 | 245,575 |
| 2019 | 238,619 |
| 2020 | 249,093 |
| 2021 | 274,850 |
| 2022 | 257,922 |
| 2023 | 253,676 |
| 2024 | 261,106 |
| 2025 | 235,525 |
| 2026 | 263,830 |
Filings made before the SEC required XML are listed, not extracted.